Your session is about to expire
← Back to Search
Neuromodulation Device
Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury
N/A
Waitlist Available
Led By Jeremy B Myers, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of sacral neuromodulation on bladder function & quality of life in patients w/ acute spinal cord injury.
Eligible Conditions
- Spinal Cord Injury
- Urinary Tract Infection
- Bladder control issues
- Neurogenic Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Sacral neuromodulationExperimental Treatment1 Intervention
Bilateral sacral neuromodulation will start within 3 months of spinal cord injury, as well as standard neurogenic bladder care.
Group II: Standard careActive Control1 Intervention
Patients will receive standard neurogenic bladder care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrimeAdvanced Surescan 97702 Neurostimulator - Medtronic (Minneapolis, MN)
2019
N/A
~50
Find a Location
Who is running the clinical trial?
University of MichiganOTHER
1,863 Previous Clinical Trials
6,441,533 Total Patients Enrolled
Rancho Research Institute, Inc.OTHER
7 Previous Clinical Trials
465 Total Patients Enrolled
University of UtahLead Sponsor
1,147 Previous Clinical Trials
1,699,072 Total Patients Enrolled
Wake Forest University Health SciencesOTHER
1,403 Previous Clinical Trials
2,478,287 Total Patients Enrolled
Jeremy B Myers, MDPrincipal InvestigatorUniversity of Utah